Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance.

DEA/NO elicited dose‐dependent increases in LVEDP in non‐diabetic hearts (Figure S10A,C ), which did not reach statistical significance in response to Angeli's salt in non‐diabetic or diabetic hearts (Figure S10B,C ). 3.5.

also in 111,027 other papers